Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo

Episurf agreed to acquire a 164-property portfolio from KlaraBo with an underlying agreed property value of MSEK 897 and a preliminary purchase price of approximately MSEK 361 (after a 5.15% deferred latent capital gains tax deduction). Payment is via two promissory notes (MSEK 231 repayable over two-to-three years; MSEK 130 to be offset through a directed issue of up to 2,888,888,888 series B shares at SEK 0.045 each, implying up to 65.1% immediate dilution), and KlaraBo will provide a potential cash loan to cover funding shortfalls; the portfolio yields approx. MSEK 73.4 in annual rental income and total lettable area ~57,250 m2 (book value ~MSEK 913 as of 30 Sep 2025). Closing is conditional on approval by the Swedish Inspectorate for Strategic Products, securing external financing and a shareholder resolution to amend the company’s articles, with completion expected in H1 2026.

Analysis

Market structure: Episurf's pivot concentrates downside on EPIS B holders while directly benefiting KlaraBo (seller) via sizeable equity consideration and cash loan support. The acquisition effectively transfers a ~MSEK 73.4 recurring rental stream onto a sub-MSEK 361 purchase price (implied gross yield ~20%), signalling a potential arbitrage if assets are revalued on Episurf's balance sheet—but only if financing and approvals clear. For Swedish real-estate incumbents (Balder BALD B, Hemsö HMSO) the deal increases comparative visibility for high-yield residential assets and may compress cap-rate dispersion in small-cap REITs.

Risk assessment: Immediate risks: dilution (up to 65% in worst case) and general-meeting approval on 10-Apr-2026; regulatory blocking by the Swedish Inspectorate (SvP) or failure to secure external financing are 20–40% probability tail events that would crash EPIS B. Short-term (weeks–months) operational risks include integration, lease roll risk in Bollnäs/Trelleborg and latent tax adjustments; long-term risks include property price cyclicality (≥20% downside in a recession) and management credibility loss. Hidden dependency: success hinges on Episurf converting from medtech to property operator—skill set and working capital mismatch create execution risk.

Trade implications: Tactical short EPIS B ahead of the General Meeting and SvP decision (size 2–3% NAV, target 30–50% downside, stop-loss +15% above entry, horizon 1–3 months). Long selective Swedish residential landlords (BALD B, HMSO) 2–4% each for 6–18 months to capture cap-rate re-rating; consider pair trade long HMSO / short EPIS B to isolate sector vs idiosyncratic risk. Use options: buy EPIS B puts or put spreads expiring Jun–Sep 2026 to cap risk; sell covered calls on long REIT positions to enhance yield.

Contrarian angles: Consensus will view this as desperation dilution; but if SvP approval and financing succeed, Episurf could report immediate NAV uplift given low purchase price vs book value—equity could recover materially in 6–12 months. The market likely underprices the recurring rental cash flow (MSEK 73.4) and overprices governance dilution risk; selective event-driven buyers could acquire EPIS B equity post-approval at >50% discount to implied NAV. Unintended consequence: seller (KlaraBo) exposure to Episurf equity concentrates counterparty risk—monitor KlaraBo share moves as a leading indicator.

Key Decisions for Investors

• Establish a short position in EPIS B (Episurf Medical) sized 2–3% of portfolio NAV ahead of the General Meeting (10-Apr-2026) and SvP decision; set target 30–50% downside within 1–3 months, stop-loss at +15% to limit blow-up risk.
• Initiate 2–4% long positions in Swedish residential landlords BALD B (Balder) and HMSO (Hemsö) with 6–18 month horizon to capture relative rerating of high-quality income-generating housing assets; average-in on any 10% pullbacks.
• Execute a pair trade: long HMSO (2% NAV) / short EPIS B (2% NAV) to isolate real-estate beta from Episurf idiosyncratic execution risk; rebalance after SvP decision.
• Buy EPIS B put spreads (expires Jun–Sep 2026) as cheaper downside protection if options liquidity allows; alternatively buy outright deep-OTM puts sized to cap downside to 1% NAV. Monitor three catalysts before adding risk: (a) SvP ruling (expected H1 2026), (b) General Meeting on 10-Apr-2026, (c) confirmation of external financing within 60 days; reduce positions if any catalyst is missed.